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Review Review of Journal of Cardiovascular Magnetic 
Resonance 2009
DJ Pennell*1, DN Firmin1, PJ Kilner1, WJ Manning2, RH Mohiaddin1, S Neubauer3 and SK Prasad1
Abstract
There were 56 articles published in the Journal of Cardiovascular Magnetic Resonance in 2009. The editors were 
impressed with the high quality of the submissions, of which our acceptance rate was about 40%. In accordance with 
open-access publishing, the articles go on-line as they are accepted with no collating of the articles into sections or 
special thematic issues. We have therefore chosen to briefly summarise the papers in this article for quick reference for 
our readers in broad areas of interest, which we feel will be useful to practitioners of cardiovascular magnetic 
resonance (CMR). In some cases where it is considered useful, the articles are also put into the wider context with a 
short narrative and recent CMR references. It has been a privilege to serve as the Editor of the JCMR this past year. I 
hope that you find the open-access system increases wider reading and citation of your papers, and that you will 
continue to send your quality manuscripts to JCMR for publication.
Ventricular volumes, function and mass
A dual propagation contours technique for semi-
automated assessment of systolic and diastolic cardiac 
function
Despite the known accuracy and reproducibility of CMR
for the measurement of ventricular volumes and mass
based on manual contour delineation, given the effort
required, there is great enthusiasm for improvement and
especially automation of the analysis. Recent papers have
focussed on accelerated imaging [1,2], right ventricular
(RV) function [3], and diastolic function [4]. In this study,
Feng described a novel approach to semi-automated seg-
mentation of the left ventricle (LV) with the aim of more
accurately derive ejection and filling rates from volume
time curves [5]. They used manually drawn end-systolic
and end-diastolic contours and their algorithm used both
forward and backward propagation to identify the rest of
the contours. In both normals and hypertensive patients,
this approach was shown to more closely follow through-
out the cardiac cycle the manually drawn contours than
previously described approaches that use only forward
propagation from one time point. The automated analysis
time saving (vs the manual approach) was considerable
with an analysis time reduction from 4 hours to just 7
minutes.
Electrocardiographic (ECG) criteria for determining LV mass 
in young healthy men; data from the LARGE Heart study
Doubts remain over the use of the ECG in identifying
those with LV hypertrophy (LVH), which is particularly
marked in young individuals because of high prevalence
of ECG criteria for LVH. Sohaib compared ECG criteria
of LVH with CMR as a gold standard in 101 male army
recruits [6]. The paired sensitivity and specificity values
for 4 ECG indices of LVH showed poor accuracy and the
authors concluded that they have little value in young fit
males.
Determinants of LV mass in obesity
This study examined a group of 38 obese individuals,
without additional cardiovascular disease risk factors,
compared to normal weight controls [7]. LV mass and
volumes were assessed with CMR. From a large set of
CMR and anthropometric measurements, the study
sought to determine the main predictors of LV mass.
These were found to be lean body mass, LV stroke vol-
ume and abdominal visceral fat mass. These findings help
with our understanding of the determinants of LV hyper-
trophy in obesity. * Correspondence: d.pennell@ic.ac.uk
1 CMR Unit Royal Brompton Hospital, Sydney Street, London SW3 6NP UK. 
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Myocardial tissue tagging with cardiovascular magnetic 
resonance
This article reviewed the current state and applications of
myocardial tagging using CMR [8]. Emphasis is given to
its role in detection in subclinical myocardial disease.
There is considerable interest in this technique, both in
humans and animals [9,10]. and also in related techniques
such as strain encoding [11].
Comparison of 2D and 3D calculation of LV torsion as 
circumferential-longitudinal shear angle using 
cardiovascular magnetic resonance tagging
This study compared LV torsion based on the circumfer-
ential - longitudinal shear angle using 2D and 3D quanti-
fication. Both methods were effective although the 2D
method was faster [12].
Effects of deep sedation or general anesthesia on cardiac 
function in mice undergoing CMR
This paper examined the effects of mild sedation, deep
sedation and general anaesthesia (GA) on heart rate and
LV ejection fraction (EF), using both CMR and echocar-
diography [13]. In normal mice, heart rate and LVEF
decreased on deep sedation, and more so on GA, while
there were no such differences in mice with chronic heart
failure. This study demonstrates the significant impact of
different sedation/anaesthesia regimes on cardiac func-
tion. It also suggests that experiments under deep seda-
tion are feasible and an alternative to GA, yielding more
accurate measurements of cardiac function.
Flow evaluation and valve disease
Three dimensional three component whole heart CMR 
velocity mapping: comparison of flow measurements from 
3D and 2D acquisitions
Brix described the application of multidirectional time
resolved 3D or 7D phase contrast velocity mapping CMR
to provide comprehensive flow data with whole heart
coverage [14]. The resulting data were used to derive
quantitative flow data which are compared to more tradi-
tional higher spatial and temporal resolution 2D datasets.
These methods and in particular the application for the
assessment and analysis of whole heart flow are of inter-
est because the acquisitions can be made without pre-
planning and the flow in any plane can be analysed
retrospectively. This study showed that the volume flows
measured from the 7D data compared well to the mea-
surement from predefined 2D single velocity direction
acquisitions. Multidirectional flow analysis may find a
useful role in understanding the pathophysiology of
abnormalities of the vascular system [15].
Pulmonary intravascular blood volume changes through 
the cardiac cycle in healthy volunteers studied by CMR 
measurements of arterial and venous flow
In a novel attempt to measure the cyclic changes of the
volume of blood contained in the pulmonary vessels and
microvessels, Ugander used CMR phase contrast mea-
surements of flow through the pulmonary trunk and the
four pulmonary veins in 10 healthy subjects [16]. This
carefully performed study contributes new information
to the relatively sparse literature on the biomechanical
properties of healthy human pulmonary vasculature.
The effects of breath-holding on pulmonary regurgitation 
measured by CMR velocity mapping
Breath hold acquisitions, usually after expiration, are
w i d e l y  u s e d  i n  C M R .  M e a s u r e m e n t  b y  p h a s e  c o n t r a s t
velocity mapping in patients with repaired tetralogy of
Fallot by Johansson [17]. indicated that expiratory breath
holding reduced pulmonary regurgitant fraction com-
pared with held inspiration or free breathing. Altered air-
way pressure may be a contributory factor.
Biventricular adaptation to volume overload in mice with 
aortic regurgitation
This study investigated the hypothesis that hypercholes-
terolaemia leads to aortic regurgitation due to lipid depo-
sition and fibrosis of the aortic valve [18]. This was
investigated in normal control and hypercholesterolae-
mic mice, using CMR to assess aortic regurgitation and
LV volumes. The prevalence and severity of aortic regur-
gitation was significantly increased in hypercholestero-
laemia, and aortic regurgitation led to LV remodelling in
hypercholesterolaemic mice. This study establishes a link
between hypercholesterolaemia and aortic regurgitation,
suggesting that systematic human studies of this topic are
warranted, and also points towards a prophylactic treat-
ment of aortic regurgitation.
CMR of quinticuspid aortic valve with aortic regurgitation 
and dilated ascending aorta
Bicuspid aortic valves are unusual, the quadricuspid form
is rare and the quinticuspid form is exceptional [19]. Few
readers are likely to have seen images of a quinticuspid
aortic valve before publication of the remarkable images
submitted by Meng.
Aortic valve stenotic area calculation from phase contrast 
CMR: the importance of short echo time
CMR has been shown to underestimate aortic flow in tur-
bulent high velocity jets due to intra-voxel dephasing.
T h i s  s t u d y  i n v e s t i g a t e d  t h e  e f f e c t  o f  d e c r e a s i n g  i n t r a -
voxel dephasing by reducing the echo time (TE) on aortic
valve area (AVA) estimates in patient with aortic valve
stenosis [20]. The authors showed that agreement of
CMR AVA with echocardiography improves with reducePennell et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:15
http://www.jcmr-online.com/content/12/1/15
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TE to 1.5 ms. Further improvements or novel more
robust CMR phase contrast methods are suggested to
improve assessment of severity of moderate-to-severe
aortic stenosis. This report emphasises the need for con-
tinuing optimisation of CMR techniques in the measure-
ment and assessment of valve regurgitation [21,22]. and
stenosis.
Electrocardiographic (ECG) diagnosis of LVH in aortic valve 
disease: evaluation of ECG criteria by CMR
This study examined ECG indices of concentric and
eccentric LVH in patients with aortic valve disease and in
healthy subjects, calibrated against CMR measurements
of cardiac volumes and mass [23]. Several ECG indices of
hypertrophy were assessed, which all correlated with
CMR parameters, but the Romhild-Estes score was the
most powerful index. Concentric and eccentric LVH
could be distinguished by differences in intrinsicoid
deflection and ST-segment and T wave changes. This
study adds to our knowledge on the relationship between
electrical and anatomical indices of LV hypertrophy.
Congenital & Pediatric
Improved accuracy in flow mapping of congenital heart 
disease using stationary phantom technique
Miller addressed the issue of errors in derived measure-
ments of flow that are attributable to background offset
errors in CMR phase contrast velocity acquisitions [24].
They applied a static phantom correction approach, pre-
viously reported by Chernobelky [25]. to clinical CMR
studies of flow in 31 patients with congenital heart dis-
ease. Although flow measurements across their popula-
tion of patients showed relatively little mean error, they
found errors for some individual patient studies were sig-
nificant, but could be satisfactorily corrected by the sub-
sequent use of static phantom acquisitions.
Normal RV and LV volumes and myocardial mass in children 
measured by steady state free precession
The CMR study by Valsangiacomo Buechel of RV and LV
volumes and mass in 50 children without known cardio-
vascular disease undergoing steady state free precession
(SSFP) CMR made an important contribution to the liter-
ature by recording reference values relative to body sur-
face area [26]. The paper complements and supports
another recently reported study [27]. and adds to the
growing literature on CMR in children [28,29].
Feasibility of perfusion CMR in paediatric patients
Concerns regarding the effects of ionizing radiation make
CMR study of myocardial perfusion a potentially attrac-
tive option, particularly for younger patients. Valsangia-
como Buechel reports the results of first pass adenosine
stress CMR perfusion studies in 47 patients between 1
month and 18 years of age, most of whom had either
Kawasaki disease, previous arterial switch or Ross opera-
tion [30]. General anaesthesia was used for 18 of the stud-
ies. Sixteen of the CMR perfusion studies were judged to
be abnormal, giving a sensitivity of 87% (CI 52-97%) and a
specificity of 95% (CI 79-99%) relative to the presence of
corresponding angiographically demonstrated coronary
stenosis.
Pericardium and tumours
CMR in pericardial diseases
This is an excellent comprehensive review of contempo-
rary knowledge of how CMR can be used to study most
common pericardial diseases [31]. The review is well
illustrated and referenced. Strong points in favour of
using CMR for imaging in pericardial disease are the inte-
gration of anatomic and functional information within a
single examination; tissue characterization to determine
inflammation and activity of the disease and the value of
CMR to accurately assess the rats of the heart, particu-
larly the myocardium, helpful in the differential diagno-
sis, which often remain a diagnostic challenge.
Validation of CMR assessment of pericardial adipose tissue 
volume
Pericardial adipose tissue has been shown to be an inde-
pendent predictor of coronary artery disease. In this
study CMR-derived pericardial adipose tissue volume has
been shown to be accurately reflected pericardial adipose
tissue mass in ovine model [32]. The technique is ideally
suited for future studies of the role of pericardial adipose
tissue in cardiovascular risk prediction and disease in
clinical practice.
Dressler's syndrome demonstrated by late gadolinium 
enhancement (LGE) CMR
This interesting case report demonstrated global pericar-
dial inflammation late post-myocardial infraction visual-
ized by LGE on CMR [33]. This may be clinically useful
when trying to establish a cause for atypical post-myocar-
dial infarction pain without requiring exposure to inva-
sive procedures of ionizing radiation.
CMR diagnosis of cystic tumor of the atrioventricular node
CMR is well established for assessment of cardiac tumors,
which may show characteristic signal behaviour with T1
and T2 weighted sequences, as well as response to gado-
linium [34,35]. In this case report, LGE CMR was shown
to be useful for characterizing a rare primary cystic
tumor of the atrioventricular node of a patient with
recent syncope and abnormal AV nodal function referred
for CMR for a suspected atrial myxoma [36]. Cine SSFP
CMR demonstrated a 2.5 cm hypointense mass at the AV
node with prominent homogeneous LGE. At surgery , a
multicystic tumor was identified.Pennell et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:15
http://www.jcmr-online.com/content/12/1/15
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Cardiomyopathy
CMR findings in patients with hypertrophic 
cardiomyopathy (HCM) and atrial fibrillation
CMR has made possible major clinical advances in the
phenotyping [37]. and risk assessment [38]. of a broad
range of cardiomyopathies and a recent JCMR review on
arrhythmogenic right ventricular cardiomyopathy
(ARVC) has been one of the most accessed recent articles
[39]. The assessment of risk in HCM is challenging clini-
cally, and scarring shown by LGE may play a useful role,
even in phenotypically normal HCM gene carriers [40].
Atrial fibrillation in HCM carries an adverse prognosis,
and early detection is important but challenging. In this
study by Papavassiliu, patients with LGE were shown to
be more likely to develop atrial fibrillation [41]. However,
left atrial dilatation which is a conventional risk factor for
atrial fibrillation was a stronger predictor, indicating that
further work is needed in this area to tease out the inter-
play between scarring and ventricular compliance in the
genesis of atrial fibrillation.
Early manifestation of alteration in cardiac function in 
dystrophin deficient mdx mouse using 3D CMR tagging
Patients with Duchenne muscular dystrophy may develop
dilated cardiomyopathy, even at young age. This study
assessed the ability of CMR tagging to detect subtle alter-
ations in LV function in a genetic model of Duchenne
muscular dystrophy, the mdx mouse [42]. Compared to
control mice, mdx showed an early increase in myocar-
dial regional strain and torsion, and a decrease later in
life. At all time points, global LV function measurements
were similar between groups. This study suggests that
CMR tagging may be a sensitive technique to detect sub-
tle alterations in cardiac function in patients with this dis-
order.
T2 quantification for improved detection of myocardial 
edema
T2 weighted CMR has been used in patients with myo-
carditis [43,44] and acute myocardial infarction, in which
it is useful in helping to differentiate acute from chronic
myocardial infarction. However, T2 weighted imaging is
sensitive to coil sensitivity and motion. In a phantom
study, Giri studied several methods of T2 mapping [45].
T2-prepared SSFP demonstrated greater accuracy in esti-
mating T2 of phantoms as compared with fast spin echo
approaches. The optimized method was then applied to
healthy subjects and a swine model of acute infarction
and small patient subgroup. The T2 of normal myocar-
dium was found to be 52.2 +/- 3.4 ms. Importantly, the T2
maps were found to be insensitive to phased array coil
sensitivity and cardiac motion, thereby providing poten-
tial for increased accuracy for the detection of myocardial
edema.
CMR in the diagnosis of acute heart transplant rejection: a 
review
In this review article, Butler reviews the role of CMR in
the diagnosis of acute heart transplantation, including
edema imaging and LGE [46]. Whilst CMR is not a main-
stream clinical test in these circumstances, further
research may establish a clearer clinical role in the future.
Recovery of methamphetamine associated 
cardiomyopathy predicted by LGE CMR
Myocardial LGE is usually absent in cardiomyopathies
which can recover, such as Takotsubo and myocardial
siderosis [47], and when present LGE suggests a non-
reversible course as in the cardiomyopathy associated
with trastuzumab [48]. It is well established that certain
medications can cause a cardiomyopathy, and in this
report reversible ventricular dysfunction was associated
with the use of methamphetamine [49]. LGE was absent
in this case, and predicted recovery at 6 months after ces-
sation of the drug insult.
Cardiac injuries in blunt chest trauma; CMR of myocardial 
infarction after blunt chest trauma: a heartbreaking soccer-
shot
The editors of JCMR were intrigued to receive two sepa-
rate reports of myocardial damage attributable to exter-
n a l  c h e s t  t r a u m a  wi t h i n  a  w ee k  o f  e a c h  o t h e r .  M a ri n a
Higuet showed evidence of a relatively extensive infarc-
tion involving septal, inferior and lateral regions of the LV
in a 12 year old boy who had been run over 6 years previ-
ously [50]. In a second case, they reported evidence of
rupture of the interventricular septum in a 45 year old
man, investigated the day after he suffered compression
in a collapsed trench. In both cases, it was suggested that
sudden expansion of the RV and consequent tension on
the moderator band may have contributed to the myocar-
dial damage seen. If so, compression of the abdomen and
its venous reservoir might also have contributed. The
case reported by Hannibal Baccouche showed numerous
focal patches of LGE in a 26 year old man after a high
velocity impact to the chest while playing soccer [51].
Acute chest pain suffered by the young man soon after
the trauma and angiographic evidence of proximal left
anterior descending stenosis and more distal occlusion
suggested traumatically induced coronary thrombosis
and embolisation.
The efficacy of iron chelator regimes in reducing cardiac 
and hepatic iron in patients with thalassaemia major: a 
clinical observational study
A major success story for CMR has been the demonstra-
tion that quantification of cardiac iron through the use of
myocardial relaxation measurements. T2* has in general
been preferred to T2 (both are feasible) because of ease of
acquisition [52,53]. Cardiac iron assessment allows thePennell et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:15
http://www.jcmr-online.com/content/12/1/15
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identification of patients of high risk of developing toxic
cardiomyopathy that can be averted by early intensive
iron chelation treatment. This is associated with a 71%
reduction in cardiac mortality in beta-thalassemia major
[54]. which is the most prevalent condition worldwide
associated with transfusion dependency. Now thrown
into sharp focus is the relative efficacy of the 3 clinically
available iron chelators in removing cardiac iron and pre-
venting the onset of heart failure [55]. Berdoukas used
paired T2* CMR scans in 232 patients to compare chela-
tion regimes in a non-randomised analysis, which is not
rigorous but can give an indication of differences in clini-
cal cardiac efficacy [56]. The combination treatment with
both deferoxamine and deferiprone was the most effec-
tive treatment for the heart, whilst monotherapy with
deferiprone or deferasirox were preferentially effective in
the heart and liver respectively. Randomised comparisons
of the 2 oral iron chelators would be welcome, but face
significant hurdles in funding.
Saw-tooth cardiomyopathy
This is a very unusual case of cardiomyopathy in a young
infant. Left ventricular dysplasia and inward sawtooth
like projections were present [57]. The clinical profile and
implications are discussed.
CMR findings in a case of Danon disease
Danon disease is a rare X-linked dominant, lysosomal
glycogen storage caused by LAMP-2 protein deficiency
which is usually diagnosed using immunofluorescence in
striated muscle. It is known to cause a HCM phenotype.
In this rare patient, very marked and widespread LGE
was present which was largely absent in the septum,
which would be unusual for HCM [58]. The diagnosis
should be considered in males with coexisting mental
retardation/learning difficulties, skeletal myopathy or
muscle weakness. Mental retardation or skeletal myopa-
thy can be present in female carriers, but less commonly
than in affected males.
Atheroma and vascular
Dual stack black blood carotid artery CMR at 3T: 
Application to wall thickness visualization
The authors proposed a novel approach for rapid imaging
of lar ge sections of t he carotid artery wall a t isotr opic
spatial resolution [59]. Using an interleave acquisition of
two 3D stacks with proposed motion sensitized seg-
mented steady-state black blood gradient echo technique,
coverage of the carotid artery trees on both sides was
achieved in reasonable time. Application of this tech-
nique in 10 patients showed that thickening of the vessel
wall can be identified and the suspicious segments can be
targeted for subsequent high-resolution CMR.
High resolution carotid black-blood 3T CMR with parallel 
imaging and dedicated 4-channel surface coils
Saam and colleagues presented a study that demonstrated
the applicability of carotid CMR at 3T [60]. In their study
the group employed a 4 channel surface coil and used this
to demonstrate a good combination of signal to noise,
pixel size and scan time for a multi sequence carotid
imaging protocol.
Prediction of coronary artery disease by a systemic 
atherosclerosis score index derived from whole-body MR 
angiography (MRA)
Whole body MRA catches the imagination and is used in
clinical practice [61]. There is an association between
extra-cardiac and coronary atherosclerosis, although this
is variable [62]. This study provided important new data
on this association [63]. Whole body MRA derived sys-
temic sclerosis score index was shown not only associated
with established cardiovascular risk scores but is also pre-
dictive of significant coronary artery disease. This sug-
gests potential prognostic implications of this approach
and underlines the importance of screening for coronary
artery disease in patients with extra-cardiac manifesta-
tions of atherosclerosis.
CMR parameters of atherosclerotic plaque burden improve 
discrimination of prior major adverse cardiovascular events
The prevalence and burden of aortic and carotid athero-
sclerosis in patients with prior major cardiovascular and
cerebrovascular events (MACE) was examined in a black
blood CMR study of 195 subjects [64]. Patients with a
MACE history had higher plaque burden (wall thickness,
wall area, and normalized wall area). After adjustment for
age, sex, and traditional risk factors, carotid artery plaque
eccentricity was also associated with prior MACE.
The added value of longitudinal black-blood CMR 
angiography in the cross sectional identification of carotid 
atherosclerotic ulceration
This study showed that additional value of longitudinal
black-blood CMR angiography to multislice cross-sec-
tional CMR images for assessing carotid artery disease as
it increases accuracy in the identification of carotid ath-
erosclerotic ulceration [65].
Effect of rosiglitazone on progression of atherosclerosis: 
insights using 3D carotid CMR
There has been evidence suggesting that rosiglitazone
increases death from cardiovascular causes, but this is
controversial. Varghese performed a randomized, pla-
cebo-controlled, double-blind study to evaluate the effect
of rosiglitazone treatment on carotid atherosclerosis in
subjects with type 2 diabetes with a primary endpoint of
the change from baseline in carotid arterial wall volume,
r e f l e c t i n g  p l a q u e  b u r d e n ,  a s  m e a s u r e d  b y  C M R  [ 6 6 ] .Pennell et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:15
http://www.jcmr-online.com/content/12/1/15
Page 6 of 12
There were no significant differences between groups
after 1 year of treatment which did not suggest that pro-
gression of atheroma was a likely cause for the possible
excess mortality seen with rosiglitazone, and therefore
other mechanisms should be examined.
CMR in carotid atherosclerotic disease
This is an excellent review of techniques and clinical
applications of CMR in carotid atherosclerotic disease by
a well known group with extensive experience in this field
[67]. The review is well illustrated with comprehensive
list of references and provides state of the art summary of
current knowledge in this area.
Coronary artery disease
Appearance of microvascular obstruction on high 
resolution first-pass perfusion, early and LGE CMR in 
patients with acute myocardial infarction
Mather used their high resolution perfusion imaging
sequence to investigate the important question regarding
how well the conventionally used LGE methods can
assess the extent of microvascular obstruction (MO) [68].
The high resolution perfusion sequence used a spatio-
temporal undersampling method, k-t SENSE to acceler-
ate the data acquisition by a factor of 7 times. The results
showed that in patients with recent acute myocardial
infarction, successfully treated with percutaneous coro-
nary intervention, high-resolution first-pass perfusion
CMR identified more cases of microvascular obstruction
than either early or LGE images and that the extent of
microvascular obstruction also appears larger on the per-
f u s i o n  s c a n s .  I n  t h e i r  c o n c l u s i o n  t h e y  p o s t u l a t e d  t h a t
first-pass perfusion imaging was likely to have given the
m o s t  a c c u r a t e  a s s e s s m e n t  o f  M O ,  a s  i t  w a s  n o t  c o n -
founded by the diffusion of gadolinium into the no-reflow
zone over time, a phenomenon that would lead to an
underestimation of microvascular obstruction by any
LGE, regardless of timing.
Comparison of wall thickening and ejection fraction by 
CMR and echocardiography in acute myocardial infarction
LV function and wall motion are routinely assessed post
percutaneous coronary intervention in evaluating the
success of the technique, and using both echo or CMR
[69]. The study shows that both techniques have limita-
tions, particularly at the early stage post infarction,
although these are less marked by 4 months.
Infarct evolution in man studied in patients with first-time 
coronary occlusion in comparison to different species - 
implications for assessment of myocardial salvage
Scar and ischemic burden are now readily measured in
humans using CMR [70]. Although the time course of
infarct evolution (how fast myocardial infarction devel-
ops during coronary artery occlusion), is well known for
several species, evidence in humans is limited. Hedström
recruited 16 patients with acute myocardial infarction
and compared the myocardium at risk by SPECT and T2-
weighted CMR with ultimate infarct size measured by
LGE [71]. The time to reach 50% infarction of the myo-
cardium at risk was 288 minutes, which is significantly
longer than seen in pigs, rats and dogs. Whilst this study
has limitations, it is provocative and suggests that further
work is needed in this area to determine
Prognostic value of adenosine stress CMR in patients with 
low-risk chest pain
Perfusion CMR is rapidly entering clinical practice in
many centres around the world [72]. and is easily com-
bined with other CMR techniques in a comprehensive
assessment protocol [73]. There is considerable promise
in new techniques [74], including acquisition acceleration
[75], post-exercise imaging [76], and the use of 3T [77-
79]. In this study , perfusion CMR is used in the emer-
gency setting, where approximately 5% of patients with
an acute coronary syndrome are discharged from the
emergency room with an erroneous diagnosis of non-car-
diac chest pain. This study evaluated the negative prog-
nostic value of adenosine perfusion CMR among 103
low-risk acute chest pain patients [80]. Patients were fol-
lowed for a mean of 277 days for a combined endpoint of
cardiac death, nonfatal acute myocardial infarction, re-
hospitalization for chest pain, obstructive coronary artery
disease (> 50% coronary stenosis on invasive angiogra-
phy) or coronary revascularization. Adenosine perfusion
CMR was negative in 89 patients (86.4%), and none of
these patients reached the primary endpoint. The authors
conclude that adenosine perfusion CMR holds promise
as a useful tool to rule out significant coronary artery dis-
ease in patients with low-risk chest pain, as patients with
negative adenosine stress CMR have an excellent short
prognosis.
Variability of myocardial perfusion dark rim Gibbs artifacts 
due to sub-pixel shifts
Ferreira and colleagues published a technical note
describing a subtle feature of the Gibbs ringing dark rim
perfusion artifact that had not previously been discussed
[81]. The authors showed that the extent of the artifact
was dependant on the exact position of the blood myo-
cardial border of the heart with respect to the imaging
pixels. This could explain some of the unpredictability of
dark rim artifacts from subject to subjects and even in the
same subject over the acquisition.
Adverse effect of increased LV wall thickness on five year 
outcomes of patients with negative dobutamine stress
Dobutamine stress CMR is being used in many centres
a n d  s o m e  n e w  a p p r o a c h e s  h a v e  b e e n  r e p o r t e d  [ 8 2 ] .
although it remains less popular than perfusion CMR.Pennell et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:15
http://www.jcmr-online.com/content/12/1/15
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The 5-year prognostic value of LVH in patients with a
negative dobutamine/atropine SSFP CMR stress was
assessed in a 175 patient study of patients with a normal
LVEF (> 55%) and no inducible wall motion abnormality
[83]. In a multivariate analysis, wall thickness ≥ 12 mm
was associated independently with an increase of cardiac
death and myocardial infarction (OR 6.0, p = 0.002) and
the combined end-point of cardiac death, myocardial
infarction, unstable angina, and congestive heart failure
warranting hospitalization (HR 3.0, p = 0.0005).
Quantification of LGE CMR in viability assessment in 
chronic ischemic heart disease: a comparison to functional 
outcome
Scar volume assessed by LGE CMR is known to predict
future cardiac events [84]. The prediction of recovery of
LV systolic function after revascularisation can be made
in several ways [85]. but the use of LGE CMR to assess
residual viability in association with scar is now in wide-
spread clinical use. There has been considerable debate
over the best quantitative technique to measure the
extent of LGE, either in absolute terms or in relation to
LV mass. This is not only more rigorous than qualitative
assessment by scoring in the setting of clinical trials, but
is more reproducible. This study evaluated the quantifi-
cation of LGE in relation to the clinical standard of viabil-
ity, namely functional outcome 6 months after
revascularization [86]. LGE was quantified by threshold-
ing window setting at 2-8 SD above mean signal intensity
of a remote normal region, and according to the full
width at half maximum method. Dysfunctional segments
were divided in 5 groups according to segmental extent of
enhancement. The quantification methods had a strong
influence on the total infarct size, but although 6SD was
the best in predicting segmental functional outcome after
revascularization, the difference with other methods was
small and non-significant. Thus the authors argue that
whilst the quantification technique is important for
quantification of infarct extent, the various techniques
are similar for prediction of regional viability.
Cell tracking and therapy evaluation of bone marrow 
monocytes and stromal cells using SPECT and CMR in a 
canine model of myocardial infarction
This study establishes a new large animal model suitable
for the assessment of stem cell therapy for myocardial
infarction [87]. Autologous bone marrow monocytes and
stromal cells were used, and cell imaging achieved with
111Indium-tropolone labelling. LGE CMR was used to
determine infarct shrinking. Initial results in dogs studied
for 12 weeks following a 3 hour coronary occlusion show
that monocytes produce significant treatment effects.
This new multi-modality approach should be useful for
the evaluation of new stem cell approaches to treating
myocardial infarction.
Reduced peripheral arterial blood flow with preserved 
cardiac output during submaximal bicycle exercise in 
elderly heart failure
This study addressed the problem that older patients with
heart failure typically show exercise intolerance [88]. This
could be due to lower blood flow to the lower extremities
due to reduced cardiac output, or due to other mecha-
nisms. Patients and controls were studied with CMR to
measure aortic and lower extremities blood flow, and
peak oxygen consumption (VO2) was also measured. In
heart failure patients, lower extremities blood flow after
exercise was indeed reduced, but aortic flow was not.
This shows that mechanisms other than reduced cardiac
output contribute to reduced exercise tolerance in heart
failure in the elderly. The study demonstrates that exer-
cise intolerance in heart failure in the elderly isn't simply
a result of cardiac dysfunction, which may have implica-
tions for its optimal treatment.
Electrophysiology and interventional
CMR guided electrophysiology studies
The role of CMR guided electrophysiology studies was
addressed in a review by the Johns Hopkins group [89].
Pre-procedure CMR was noted to improve the under-
standing of the anatomic basis of complex arrhythmias
with a unique advantage of CMR identified as its ability to
visualize prior ablation lesions using high-resolution LGE
methods. Such information could then be applied to
assess ablation lesion location and the potential identifi-
cation of factors leading to procedure success and failure.
The ability to perform intra-procedure real-time CMR to
identify complex 3D arrhythmogenic anatomy and to tar-
get additional ablation areas was identified as future ini-
tiatives along with the requirement of clinical grade CMR
compatible electrophysiologic devices. This review com-
plements another recently published JCMR review on
interventional CMR [90].
Radial dyssynchrony assessed by CMR in relation to LV 
function, myocardial scarring and QRS duration in patients 
with heart failure
Mechanical dyssynchrony is a hot topic in heart failure,
because of problems in predicting response to cardiac
resynchronisation therapy (CRT). There is also debate
regarding which non-mortality endpoint is best for
assessing a good response to CRT [91]. CMR has been
proposed be useful in this field [92]. and increasing inter-
est in its use is being seen [93]. Radial dyssynchrony was
found to be highly prevalent in a CMR tissue synchroni-
zation index (CMR-TSI) study of 225 patients with heart
failure and 50 healthy controls [94]. Using a dyssynchronyPennell et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:15
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threshold of healthy control mean TSI ± 2SD, dyssyn-
chrony was found in 91% of subjects with a QRS duration
< 120 ms, 95% of those with a QRS 120-149 ms, and 99%
of subjects with a QRS ≥ 150 ms. CMR-TSI was related
positively to LV volumes and inversely with LV ejection
fraction.
CMR Visualization of coronary venous anatomy by
Combined whole heart coronary vein MRA and LGE for
patients with heart failure in whom cardiac resynchroni-
zation is being considered was retrospectively assessed in
31 subjects with known or suspected ischemic disease
[95]. Within 5 minutes after administration of 0.05
mmol/kg Gd-DTPA, whole heart coronary vein MRA
demonstrated 74% of subjects having a lateral vein, 65%
an anterior interventricular vein, and 74% a posterior
interventricular vein. Two patients had no venous
branches other than the coronary sinus and great cardiac
vein. An additional 0.15 mmol/kg of Gd-DTPA was then
administered with LGE imaging 10-15 minutes later with
5 subjects having evidence of LGE. Co-localization of
coronary vein imaging and LGE data may allow for
improved efficacy of cardiac resynchronization therapy.
Whole shaft visibility and mechanical performance for 
active MR catheters using copper-nitinol braided polymer 
tubes
Kocaturk published the development of a new active
catheter design incorporating in its shaft a wire lattice in
a polymer matrix [96]. The catheter contained three dis-
tal loop coils in a flexible and torquable 7Fr device. The
group explored the impact of braid material designs on
radiofrequency and mechanical performance. They
found a 16-wire braid of 1:1 copper:nitinol to have the
optimum balance of mechanical and antenna properties.
With that configuration, the temperature increase
remained less than 2°C during real-time CMR and the
catheter was shown to be conspicuous in vitro and  in
vivo.
New techniques
Diffusion CMR tractography of the heart
Sosnovik and colleagues presented an extremely thor-
ough review of diffusion encoding of the myocardium
[97]. Much of the manuscript is based on a recent publi-
cation of the authors and as such it focused on diffusion
spectral imaging (DSI) with application to tractography
of  ex vivo animal hearts. More conventional encoding
approaches utilizing fewer diffusion encoding directions
and b values are summarized particularly with regard to
in vivo human imaging.
CMR Elastography: Comparison with LV pressure 
measurement
Elgeti and colleagues presented early pilot data on the
application of CMR elastography to studying the heart
[98]. When further developed and validated these meth-
ods could have a major impact on clinical CMR. In this
limited study on three pigs the authors demonstrated
temporally within the cardiac cycle an earlier change in
measured shear wave amplitude than the change in the
LV diameters. The shear wave measurements also
appeared to be related to the intraventricular pressure.
SCMR papers and Registry
Society for Cardiovascular Magnetic Resonance (SCMR) 
guidelines for reporting CMR examinations
Ongoing efforts for standardization have recently
included CMR imaging protocols [99]. This has now been
extended to CMR reporting with publication of SCMR
report guidelines as an effort to provide a framework for
healthcare delivery systems to disseminate cardiac and
vascular CMR findings [100]. The SCMR recommends
reporting key elements in all documents including infor-
mation pertaining to a) site and equipment, b) patient
demographics, c) study indications, d) study perfor-
mance, e) cardiovascular imaging features of the exami-
nation, and f) concluding statements that synthesize the
study results into a comprehensive diagnosis that can be
used for planning therapy or determining prognosis. The
document is comprehensive in scope and includes rec-
ommended and optional components of the report, the
principles used to generate the final report, and suggested
communications that may occur in addition to the final
report.
Current variables, definitions and endpoints of the 
European Cardiovascular Magnetic Resonance Registry
This paper describes the European Cardiovascular Mag-
netic Resonance Registry [101]. This multicentre registry
will serve two functions: record the details of clinical
CMR scans in all participating centres; follow patients
with HCM and with coronary artery disease up annually
to obtain prognostic data. This database, once available in
several years, will serve many important functions - it will
inform about the practice of CMR in Europe and its clini-
cal utility, and it will yield important large scale prognos-
tic information on CMR parameters obtained in patients
with HCM and coronary artery disease.
SCMR President's Pages
Chris Kramer was President of the SCMR in 2009 and
wrote 2 Presidential Pages for the Journal. In the first, he
reviewed the 2009 Annual Scientific Sessions which
maintained attendance at over 1000 despite the economic
downturn, and had 100 oral abstracts and over 300 posterPennell et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:15
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presentations [102]. Membership was reported as stable
at 1685 with total assets at the end of year 2008 are up
17% from prior year. The contributions of SCMR were
highlighted in the drive to establish reimbursement for
CMR payment codes, Appropriate Use Criteria and the
Medical Imaging Drugs Advisory Committee of the FDA.
In addition, the flourishing roles of the regional chapters,
the SCMR web site (500,000 unique hits) and the many
SCMR committees were detailed. In the second Presiden-
tial page, Chris was able to report the improved impact
factor for Journal from 1.87 to 2.15, an increase of 15%
[103], and this may reflect the first signs of increased cita-
tion associated with Open Access publishing [104]. He
also detailed plans for an SCMR designed research trial
which was in the late stages of planning, and for an
update on training and credentialing, including technolo-
gists who perform CMR.
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